Abiraterone Acetate Diastereomer

Status: Under Development

Abiraterone Acetate Diastereomer is an enantiomer of abiraterone acetate prescribed for patients with castration-resistant prostate cancer. Abiraterone -acetate is a prodrug that is converted in vivo to abiraterone having an androgen biosynthesis inhibitory property.

Contact us

Additional information on Abiraterone Acetate Diastereomer

Catalogue No. VL830014
Molecular Formula C26H33NO2
Molecular Weight 391.56
Parent drug Abiraterone
IUPAC Name (3S, 8R, 9S, 10R, 13S, 14S)-10, 13-dimethyl-17-(pyridin-3-yl)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
Synonyms N/A
References Mach, Samuel, et al. “Epoxidation Is the Preferred Pathway of First-Stage Metabolism of Abiraterone Acetate in Brown Bullhead (Ameiurus Nebulosus).” Environmental Science and Pollution Research, vol. 26, no. 34, Oct. 2019, pp. 34896–904, https://doi.org/10.1007/s11356-019-06568-y.
Status Under Development

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Abiraterone Acetate Diastereomer

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.